U0G

4-(2-{[(2-hydroxyphenyl)methyl]amino}ethyl)-2,5-dimethoxybenzonitrile


Toggle HydrogenToggle Labels

Chemical Component Summary

Name4-(2-{[(2-hydroxyphenyl)methyl]amino}ethyl)-2,5-dimethoxybenzonitrile
Identifiers4-[2-[(2-hydroxyphenyl)methylamino]ethyl]-2,5-dimethoxy-benzenecarbonitrile
FormulaC18 H20 N2 O3
Molecular Weight312.363
TypeNON-POLYMER
Isomeric SMILESCOc1cc(c(cc1C#N)OC)CCNCc2ccccc2O
InChIInChI=1S/C18H20N2O3/c1-22-17-10-15(11-19)18(23-2)9-13(17)7-8-20-12-14-5-3-4-6-16(14)21/h3-6,9-10,20-21H,7-8,12H2,1-2H3
InChIKeyVWEDZTZAXHMZIL-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count43
Chiral Atom Count0
Bond Count44
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB13948 
NameN-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine
Groups experimental
Description25CN-NBOH (N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine) is a newly developed selective 5-HT2A agonist. It has been tested with regard to the head-twitch-response (HTR) model of 5-HT2A activity and effects on locomotion [L1148]. It was discovered in 2014 at the University of Copenhagen.
Synonyms
  • N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine
  • 25CN-NBOH
  • NBOH-2C-CN
Categories
  • Antidepressive Agents
  • Central Nervous System Depressants
  • Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  • Serotonin 5-HT2 Receptor Agonists
  • Serotonin Agents
CAS number1391489-32-9

Drug Targets

NameTarget SequencePharmacological ActionActions
5-hydroxytryptamine receptor 2AMDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSE...unknownagonist
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 90489020
ChEBI CHEBI:145979